Shangqin Liu
- Hematology top 5%
- Multiple Myeloma Research and Treatments 14
-
- Cytokine Signaling Pathways and Interactions 6
- Chemokine receptors and signaling 3
- Viral-associated cancers and disorders 3
- Pharmacology top 10%
- Flavonoids in Medical Research 4
-
- Glycosylation and Glycoproteins Research 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Michio KawanoSaeid AbrounHideaki IshikawaNaohiro TsuyamaFujun LiKen‐ichiro OtsuyamaZi MaMasanori Obata
- Cited by
- HematologyOncologyPharmacology
- Journals
- Blood (7 papers)International Journal of Hematology (3 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Shangqin Liu
32 papers receiving 697 citations
Peers
Comparison fields: 5 of 94
- Hematology 205
- Oncology 216
- Pharmacology 131
- Molecular Biology 417
- Cancer Research 85
Countries citing papers authored by Shangqin Liu
This map shows the geographic impact of Shangqin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangqin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangqin Liu more than expected).
Fields of papers citing papers by Shangqin Liu
This network shows the impact of papers produced by Shangqin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangqin Liu. The network helps show where Shangqin Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shangqin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 13 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 14 | |
| 6 | 2019 | 31 | |
| 7 | 2018 | 8 | |
| 8 | 2016 | 16 | |
| 9 | 2016 | 9 | |
| 10 | 2016 | 24 | |
| 11 | 2014 | 56 | |
| 12 | 2014 | 13 | |
| 13 | 2013 | 6 | |
| 14 | 2009 | 42 | |
| 15 | 2007 | 19 | |
| 16 | 2005 | 28 | |
| 17 | 2004 | 140 | |
| 18 | 2003 | 30 | |
| 19 | 2002 | 25 | |
| 20 | 2002 | 21 |
About Shangqin Liu
Shangqin Liu is a scholar working on Hematology, Oncology and Pharmacology, having authored 32 papers that have together received 711 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Cytokine Signaling Pathways and Interactions (6 papers), Flavonoids in Medical Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Chemokine receptors and signaling (3 papers), Viral-associated cancers and disorders (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (205 citations), Oncology (216 citations) and Pharmacology (131 citations). Shangqin Liu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Michio Kawano, Saeid Abroun, Hideaki Ishikawa, Naohiro Tsuyama, Fujun Li, Ken‐ichiro Otsuyama, Zi Ma, Masanori Obata, Xu Zheng and Koji Miyamoto. Their work appears in journals such as Blood, International Journal of Hematology, OncoTargets and Therapy, Scientific Reports and Renal Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.